Top 10 Companies in the Southeast Asia Amygdalin Market (2026): Market Leaders Powering Regional Health Innovation

MARKET INSIGHTS

The Southeast Asia Amygdalin market was valued at USD 12.8 million in 2024 and is projected to grow from USD 14.2 million in 2025 to USD 25.6 million by 2032, exhibiting a CAGR of 7.8% during the forecast period.

Amygdalin, also known as vitamin B17, is a naturally occurring cyanogenic glycoside found in seeds of fruits like apricots and bitter almonds. This compound has gained attention in the nutraceutical and pharmaceutical sectors due to its purported health benefits, though regulatory scrutiny varies across Southeast Asian markets. While some countries restrict its medicinal claims, others allow controlled usage in complementary therapies.

The market growth is primarily driven by increasing consumer preference for plant-based therapeutics and growing awareness of alternative medicine across the region. However, safety concerns regarding cyanide toxicity pose significant challenges to market expansion. Thailand and Malaysia currently lead regional consumption due to established traditional medicine practices, while Vietnam shows the fastest growth potential with a projected 9.2% CAGR through 2032. Key applications include dietary supplements and adjunct cancer therapies, though scientific validation remains controversial.

Southeast Asia Amygdalin Market – View in Detailed Research Report

MARKET SIZE

In 2025, the Southeast Asia Amygdalin market is estimated at USD 14.2 million, expanding to USD 25.6 million by 2032. The market is projected to reach USD 30.4 million by 2034, reflecting sustained demand for natural health ingredients.

PRODUCT DEFINITION

Amygdalin is extracted from apricot kernels and other stone fruits. It is used in dietary supplements, nutraceutical formulations, and as an adjunct therapy in oncology, although its efficacy remains debated in clinical settings.

TOP 10 COMPANIES IN THE SEASORET ASIA AMYGDALIN MARKET (2026)

1️⃣ Merck KGaA (Germany)

Headquarters: Darmstadt, Germany
Key Offering: High-purity amygdalin for pharmaceutical and research applications

Merck KGaA is a global leader in life‑science products, offering a range of high‑purity amygdalin grades that meet stringent regulatory standards. Its extensive distribution network ensures consistent supply across Southeast Asia’s pharmaceutical and nutraceutical sectors.

Sustainability & Growth Initiatives:

• Investing in green extraction technologies to reduce solvent use
• Partnering with local universities for clinical research on amygdalin efficacy
• Expanding regional manufacturing to reduce carbon footprint of supply chain

---

2️⃣ MilliporeSigma (United States)

Headquarters: Burlington, MA, USA
Key Offering: Laboratory‑grade amygdalin for research and development

MilliporeSigma supplies high‑purity amygdalin to researchers and pharmaceutical companies, supporting the development of new nutraceutical and therapeutic products. Its strong quality assurance framework aligns with the rigorous safety requirements of Southeast Asian regulators.

Sustainability & Growth Initiatives:

• Adopting renewable energy sources in production facilities
• Implementing waste‑reduction programs across the supply chain
• Collaborating with local distributors to enhance product traceability

---

3️⃣ Guangzhou Boke Science and Technology Co., Ltd. (China)

Headquarters: Guangzhou, China
Key Offering: Bulk amygdalin for nutraceutical and traditional medicine markets

Guangzhou Boke specializes in large‑scale extraction of amygdalin from apricot kernels, providing cost‑effective raw material to Southeast Asian manufacturers. The company’s focus on quality control has positioned it as a preferred supplier for food‑grade amygdalin.

Sustainability & Growth Initiatives:

• Optimizing extraction processes to lower energy consumption
• Developing eco‑friendly packaging solutions
• Expanding regional export networks through strategic partnerships

---

4️⃣ Xi’an SR Bio Technology Co., Ltd. (China)

Headquarters: Xi’an, China
Key Offering: High‑purity amygdalin for pharmaceutical and nutraceutical applications

Xi’an SR Bio Technology provides advanced extraction technologies that achieve 98% purity, catering to the stringent requirements of pharmaceutical manufacturers in Southeast Asia.

Sustainability & Growth Initiatives:

• Investing in research on controlled‑release formulations
• Implementing ISO 9001 quality management systems
• Partnering with local universities for clinical trials

---

5️⃣ Xi’an Le Sen Bio-Technology Co., Ltd. (China)

Headquarters: Xi’an, China
Key Offering: Specialty amygdalin grades for nutraceuticals

Xi’an Le Sen focuses on producing specialty grades of amygdalin that meet the needs of premium nutraceutical brands seeking natural, high‑quality ingredients.

Sustainability & Growth Initiatives:

• Developing low‑toxicity extraction methods
• Engaging in community outreach to promote safe usage
• Expanding product line to include combination herbal blends

---

6️⃣ Nutra Green Biotechnology Co., Ltd. (China)

Headquarters: Shanghai, China
Key Offering: Organic amygdalin for health‑conscious consumers

Nutra Green provides certified organic amygdalin, catering to the growing segment of consumers seeking clean‑label, natural ingredients in supplements.

Sustainability & Growth Initiatives:

• Obtaining organic certifications for all production lines
• Reducing water usage through closed‑loop systems
• Collaborating with regional farmers to source sustainably grown apricot kernels

---

7️⃣ Shaanxi Yongyuan Bio-Tech Co., Ltd. (China)

Headquarters: Xi’an, China
Key Offering: Industrial‑grade amygdalin for food additives and supplements

With a focus on large‑volume production, Shaanxi Yongyuan supplies amygdalin to food manufacturers and supplement producers across Southeast Asia.

Sustainability & Growth Initiatives:

• Implementing energy‑efficient extraction units
• Developing biodegradable packaging options
• Expanding into emerging markets such as Vietnam and Indonesia

---

8️⃣ Jiangsu Femulate Medical Technology Co., Ltd. (China)

Headquarters: Jiangsu, China
Key Offering: Pharmaceutical‑grade amygdalin for research and development

Jiangsu Femulate focuses on delivering high‑purity amygdalin for drug discovery and clinical research, supporting the development of new therapeutic candidates.

Sustainability & Growth Initiatives:

• Adopting GMP certification across all facilities
• Investing in R&D for safer, controlled‑release formulations
• Expanding distribution to key Southeast Asian markets

---

9️⃣ Xi’an Quanao Biotech Co., Ltd. (China)

Headquarters: Xi’an, China
Key Offering: Customized amygdalin blends for nutraceuticals

Xi’an Quanao offers tailored amygdalin blends that combine the compound with complementary herbs such as turmeric and graviola, catering to manufacturers seeking differentiated product categories.

Sustainability & Growth Initiatives:

• Developing standardized blend formulations for consistent potency
• Partnering with local health‑product retailers for market testing
• Implementing traceability systems for raw materials

---

🔟 Local Emerging Players

In addition to the major global suppliers, several local companies in Thailand, Vietnam, and Malaysia are emerging as niche players, focusing on organic extraction, local sourcing of apricot kernels, and innovative product formulations. These players differentiate themselves through transparent sourcing, certifications, and targeted marketing to health‑conscious consumers.

Download FREE Sample Report

Download FREE Sample Report: Southeast Asia Amygdalin Market – View in Detailed Research Report

Get Full Report

Get Full Report: Southeast Asia Amygdalin Market – View in Detailed Research Report

OUTLOOK: The Future of Amygdalin in Southeast Asia

The Southeast Asia Amygdalin market is poised for continued expansion, driven by the convergence of traditional medicine practices and modern nutraceutical innovation. As regulatory frameworks evolve to accommodate natural ingredients, manufacturers are investing in advanced extraction technologies, controlled‑release formulations, and digital commerce platforms to reach a broader consumer base.

Future Trends Shaping the Market

• Growth of controlled‑release amygdalin products to mitigate safety concerns
• Integration of amygdalin with other anticancer herbs in combination therapies
• Expansion of e‑commerce channels to penetrate restrictive markets
• Increasing emphasis on GMP and traceability to satisfy regulatory bodies
• Strategic partnerships between local manufacturers and international distributors to scale production and distribution